超适应证但靶向性明确：雷加昔布联合运动的应用 - Suppr

Suppr

超能文献

Off-label, but on-target: use of regadenoson with exercise.

作者信息

Hendel Robert C, Frost Lauren

出版信息

J Nucl Cardiol. 2013 Apr;20(2):179-81. doi: 10.1007/s12350-012-9643-5.

DOI:10.1007/s12350-012-9643-5

PMID:23143811

Abstract

摘要

相似文献

Off-label, but on-target: use of regadenoson with exercise.

J Nucl Cardiol. 2013 Apr;20(2):179-81. doi: 10.1007/s12350-012-9643-5.

A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.

J Nucl Cardiol. 2017 Feb;24(1):34-40. doi: 10.1007/s12350-015-0278-1. Epub 2015 Nov 5.

Marked ST-segment elevations during regadenoson pharmacologic nuclear stress testing.

J Nucl Cardiol. 2020 Jun;27(3):1071-1075. doi: 10.1007/s12350-019-01683-2. Epub 2019 Mar 18.

Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.

J Nucl Cardiol. 2013 Apr;20(2):197-204. doi: 10.1007/s12350-013-9679-1. Epub 2013 Feb 13.

A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

J Nucl Cardiol. 2013 Apr;20(2):185-96. doi: 10.1007/s12350-012-9641-7. Epub 2012 Nov 28.

Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.

J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):2-12. doi: 10.1016/j.jcct.2013.09.004. Epub 2013 Oct 18.

Regadenoson: a focused update.

J Nucl Cardiol. 2013 Apr;20(2):284-8. doi: 10.1007/s12350-012-9661-3.

Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.

J Nucl Cardiol. 2016 Oct;23(5):1147-1155. doi: 10.1007/s12350-015-0272-7. Epub 2015 Oct 21.

Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.

J Nucl Cardiol. 2015 Apr;22(2):248-61. doi: 10.1007/s12350-014-9981-6. Epub 2014 Oct 7.

The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

J Nucl Cardiol. 2017 Feb;24(1):112-118. doi: 10.1007/s12350-015-0303-4. Epub 2015 Nov 18.

引用本文的文献

Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System.

Mol Ther Methods Clin Dev. 2020 May 4;17:1097-1107. doi: 10.1016/j.omtm.2020.04.027. eCollection 2020 Jun 12.

Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

J Nucl Cardiol. 2017 Jun;24(3):1062-1070. doi: 10.1007/s12350-016-0452-0. Epub 2016 Mar 29.

A helping hand for regadenoson tests.

J Nucl Cardiol. 2017 Feb;24(1):41-42. doi: 10.1007/s12350-015-0298-x. Epub 2015 Oct 22.

New exercise-dipyridamole combined test for nuclear cardiology in insufficient effort: appropriate diagnostic sensitivity keeping exercise prognosis.

Arq Bras Cardiol. 2015 Aug;105(2):123-9. doi: 10.5935/abc.20150051. Epub 2015 May 29.

Regadenoson and exercise myocardial perfusion imaging: the courtship continues.

J Nucl Cardiol. 2013 Jun;20(3):324-8. doi: 10.1007/s12350-013-9695-1.

本文引用的文献

A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

J Nucl Cardiol. 2013 Apr;20(2):185-96. doi: 10.1007/s12350-012-9641-7. Epub 2012 Nov 28.

Ten common questions (and their answers) about off-label drug use.

Mayo Clin Proc. 2012 Oct;87(10):982-90. doi: 10.1016/j.mayocp.2012.04.017. Epub 2012 Aug 6.

Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.

J Nucl Cardiol. 2012 Oct;19(5):970-8. doi: 10.1007/s12350-012-9562-5. Epub 2012 May 8.

What does off-label prescribing really mean?

Arch Intern Med. 2012 May 28;172(10):759-60. doi: 10.1001/archinternmed.2012.789.

Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients.

J Nucl Cardiol. 2010 Oct;17(5):853-7. doi: 10.1007/s12350-010-9229-z. Epub 2010 Apr 23.

Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.

The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

J Nucl Cardiol. 2009 Jan-Feb;16(1):63-72. doi: 10.1007/s12350-008-9001-9. Epub 2009 Jan 20.

Regulating off-label drug use--rethinking the role of the FDA.

N Engl J Med. 2008 Apr 3;358(14):1427-9. doi: 10.1056/NEJMp0802107.

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

J Nucl Cardiol. 2007 Sep-Oct;14(5):645-58. doi: 10.1016/j.nuclcard.2007.06.114.

Off-label prescribing among office-based physicians.

Arch Intern Med. 2006 May 8;166(9):1021-6. doi: 10.1001/archinte.166.9.1021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验